Related references
Note: Only part of the references are listed.Cannabis use is associated with low plasma endocannabinoid Anandamide in individuals with psychosis
Anahita Bassir Nia et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2023)
Impact of cyclooxygenase-2 inhibition on cannabis withdrawal and circulating endocannabinoids in daily cannabis smokers
Margaret Haney et al.
ADDICTION BIOLOGY (2022)
Frequent Low-Dose ?(9)-Tetrahydrocannabinol in Adolescence Disrupts Microglia Homeostasis and Disables Responses to Microbial Infection and Social Stress in Young Adulthood
Hye-Lim Lee et al.
BIOLOGICAL PSYCHIATRY (2022)
Consensus paper of the WFSBP task force on cannabis, cannabinoids and psychosis
Deepak Cyril D'Souza et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2022)
A Sensitive Ultrahigh-Performance Liquid Chromatography/Tandem Mass Spectrometry Method for the Simultaneous Analysis of Phytocannabinoids and Endocannabinoids in Plasma and Brain
Faizy Ahmed et al.
CANNABIS AND CANNABINOID RESEARCH (2022)
The Relationship Between Circulating Endogenous Cannabinoids and the Effects of Smoked Cannabis
Tonisha Kearney-Ramos et al.
CANNABIS AND CANNABINOID RESEARCH (2022)
Cannabis use and cannabis use disorder
Jason P. Connor et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Fear extinction learning and anandamide: an fMRI study in healthy humans
Jennifer Spohrs et al.
TRANSLATIONAL PSYCHIATRY (2021)
Elevated Anandamide, Enhanced Recall of Fear Extinction, and Attenuated Stress Responses Following Inhibition of Fatty Acid Amide Hydrolase: A Randomized, Controlled Experimental Medicine Trial
Leah M. Mayo et al.
BIOLOGICAL PSYCHIATRY (2020)
Cannabinoids and the expanded endocannabinoid system in neurological disorders
Luigia Cristino et al.
NATURE REVIEWS NEUROLOGY (2020)
Lower brain fatty acid amide hydrolase in treatment-seeking patients with alcohol use disorder: a positron emission tomography study with [C-11]CURB
Laura M. Best et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Cannabis Legalization and Acute Harm From High Potency Cannabis Products: A Narrative Review and Recommendations for Public Health
Justin Matheson et al.
FRONTIERS IN PSYCHIATRY (2020)
High Fat Diet Increases Circulating Endocannabinoids Accompanied by Increased Synthesis Enzymes in Adipose Tissue
Eline N. Kuipers et al.
FRONTIERS IN PHYSIOLOGY (2019)
Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial
Deepak Cyril D'Souza et al.
LANCET PSYCHIATRY (2019)
Circulating Endocannabinoids: From Whence Do They Come and Where are They Going?
Cecilia J. Hillard
NEUROPSYCHOPHARMACOLOGY (2018)
Fatty acid amide hydrolase (FAAH) regulates hypercapnia/ischemia-induced increases in n-acylethanolamines in mouse brain
Lin Lin et al.
JOURNAL OF NEUROCHEMISTRY (2017)
Schizophrenia and depression, two poles of endocannabinoid system deregulation
Maria Rodriguez-Munoz et al.
TRANSLATIONAL PSYCHIATRY (2017)
Role of the satiety factor oleoylethanolamide in alcoholism
Ainhoa Bilbao et al.
ADDICTION BIOLOGY (2016)
FAAH Gene Variation Moderates Stress Response and Symptom Severity in Patients with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence
Primavera A. Spagnolo et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2016)
Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [11C] CURB
Isabelle Boileau et al.
BIOLOGICAL PSYCHIATRY (2016)
Sleep restriction alters plasma endocannabinoids concentrations before but not after exercise in humans
Jonathan Cedernaes et al.
PSYCHONEUROENDOCRINOLOGY (2016)
Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis
Arianna Marconi et al.
SCHIZOPHRENIA BULLETIN (2016)
Endocannabinoid signaling at the periphery: 50 years after THC
Mauro Maccarrone et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
FAAH genetic variation enhances fronto-amygdala function in mouse and human
Iva Dincheva et al.
NATURE COMMUNICATIONS (2015)
[18F]MK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users
Jenny Ceccarini et al.
ADDICTION BIOLOGY (2015)
Inhibition of COX-2-mediated eicosanoid production plays a major role in the anti-inflammatory effects of the endocannabinoid N-docosahexaenoylethanolamine (DHEA) in macrophages
Jocelijn Meijerink et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Urinary Cannabinoid Disposition in Occasional and Frequent Smokers: Is THC-Glucuronide in Sequential Urine Samples a Marker of Recent Use in Frequent Smokers?
Nathalie A. Desrosiers et al.
CLINICAL CHEMISTRY (2014)
Quantification of anandamide and 2-arachidonoylglycerol plasma levels to examine potential influences of tetrahydrocannabinol application on the endocannabinoid system in humans
Ulrike Thieme et al.
DRUG TESTING AND ANALYSIS (2014)
How Low Should You Go? Determining the Optimal Cutoff for Exhaled Carbon Monoxide to Confirm Smoking Abstinence When Using Cotinine as Reference
Karen L. Cropsey et al.
NICOTINE & TOBACCO RESEARCH (2014)
The Endocannabinoid System and the Brain
Raphael Mechoulam et al.
ANNUAL REVIEW OF PSYCHOLOGY, VOL 64 (2013)
Cerebrospinal fluid anandamide levels, cannabis use and psychotic-like symptoms
Celia J. A. Morgan et al.
BRITISH JOURNAL OF PSYCHIATRY (2013)
Impact of Prolonged Cannabinoid Excretion in Chronic Daily Cannabis Smokers' Blood on Per Se Drugged Driving Laws
Mateus M. Bergamaschi et al.
CLINICAL CHEMISTRY (2013)
Exogenous Delta9-Tetrahydrocannabinol Influences Circulating Endogenous Cannabinoids in Humans
Carmen Walter et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2013)
Population-Based Input Function Modeling for [18F]FMPEP-d2, an Inverse Agonist Radioligand for Cannabinoid CB1 Receptors: Validation in Clinical Studies
Paolo Zanotti-Fregonara et al.
PLOS ONE (2013)
Synaptamide, endocannabinoid-like derivative of docosahexaenoic acid with cannabinoid-independent function
Hee-Yong Kim et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2013)
Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers
J. Hirvonen et al.
MOLECULAR PSYCHIATRY (2012)
Intense exercise increases circulating endocannabinoid and BDNF levels in humans-Possible implications for reward and depression
E. Heyman et al.
PSYCHONEUROENDOCRINOLOGY (2012)
Endocannabinoid signal in the gut controls dietary fat intake
Nicholas V. DiPatrizio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Biomarkers of Endocannabinoid System Activation in Severe Obesity
Jack C. Sipe et al.
PLOS ONE (2010)
Measuring smoking-related preoccupation and compulsive drive: evaluation of the obsessive compulsive smoking scale
Brian Hitsman et al.
PSYCHOPHARMACOLOGY (2010)
Inhibitors of Endocannabinoid-Metabolizing Enzymes Reduce Precipitated Withdrawal Responses in THC-Dependent Mice
Joel E. Schlosburg et al.
AAPS JOURNAL (2009)
Reliability and validity of a short form of the Marijuana Craving Questionnaire
Stephen J. Heishman et al.
DRUG AND ALCOHOL DEPENDENCE (2009)
Implications of Plasma Δ9-Tetrahydrocannabinol, 11-Hydroxy-THC, and 11-nor-9-Carboxy-THC Concentrations in Chronic Cannabis Smokers
Erin L. Karschner et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2009)
Sleep deprivation increases oleoylethanolamide in human cerebrospinal fluid
Dagmar Koethe et al.
JOURNAL OF NEURAL TRANSMISSION (2009)
Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects
M. Ellgren et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Enzymatic machinery for endocannabinoid biosynthesis associated with calcium stores in glutamatergic axon terminals
Rita Nyilas et al.
JOURNAL OF NEUROSCIENCE (2008)
Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy
Stephane Potvin et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Blockade of THC-Seeking Behavior and relapse in monkeys by the cannabinoid CB1-Receptor antagonist rimonabant
Zuzana Justinova et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients:: Impact of cannabis use
F. Markus Leweke et al.
SCHIZOPHRENIA RESEARCH (2007)
Chronic use of marijuana decreases cannabinoid receptor binding and mRNA expression in the human brain
J. Villares
NEUROSCIENCE (2007)
Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity
Matthias Blueher et al.
DIABETES (2006)
Regulation of food intake by oleoylethanolamide
J Lo Verme et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Δ9-Tetrahydrocannabinol antagonizes endocannabinoid modulation of synaptic transmission between hippocampal neurons in culture
BG Kelley et al.
NEUROPHARMACOLOGY (2004)
Molecular characterization of a phospholipase D generating anandamide and its congeners
Y Okamoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors
M Melis et al.
JOURNAL OF NEUROSCIENCE (2004)
Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use
KP Chiang et al.
HUMAN MOLECULAR GENETICS (2004)
A single in-vivo exposure to Δ9THC blocks endocannabinoid-mediated synaptic plasticity
S Mato et al.
NATURE NEUROSCIENCE (2004)
Behavioral and molecular changes elicited by acute administration of SR141716 to Δ9-tetrahydrocannabinol-tolerant rats:: an experimental model of cannabinoid abstinence
S González et al.
DRUG AND ALCOHOL DEPENDENCE (2004)
Exercise activates the endocannabinoid system
PB Sparling et al.
NEUROREPORT (2003)
Brain monoglyceride lipase participating in endocannabinoid inactivation
TP Dinh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol
CJ Hillard
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2000)
Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of Δ9-tetrahydrocannabinol-tolerant rats
V Di Marzo et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Share Paper
